Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Alkermes Affirms FY2025 GAAP EPS Guidance of $1.03-$1.21 vs $1.15 Est; Affirms FY2025 Sales Guidance of $1.340B-$1.430B vs $1.385B Est

Author: Benzinga Newsdesk | July 29, 2025 07:06am
Alkermes (NASDAQ:ALKS) affirms FY2025 GAAP EPS guidance from $1.03-$1.21 to $1.03-$1.21 vs $1.15 analyst estimate. Affirms FY2025 sales outlook from $1.340 billion-$1.430 billion to $1.340 billion-$1.430 billion vs $1.385 billion estimate.

Posted In: ALKS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist